摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

gluconolactone

中文名称
——
中文别名
——
英文名称
gluconolactone
英文别名
d-gluconolactone;glucono-lactone;Glucono-6-lactone;(3R,4S,5R,6R)-3,4,5,6-tetrahydroxyoxepan-2-one
gluconolactone化学式
CAS
——
化学式
C6H10O6
mdl
——
分子量
178.142
InChiKey
WTXGYGWMPUGBAL-SQOUGZDYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.6
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    107
  • 氢给体数:
    4
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    gluconolactone盐酸一水合肼 作用下, 以 乙醇 为溶剂, 反应 6.0h, 生成 D-gluconic acid thiosemicarbazide
    参考文献:
    名称:
    Precursors for the Synthesis of Substituted 1,3,4-Thiadiazolf, C-Nucleosides, Analogues of Tiazofurin and Related Compounds
    摘要:
    The synthesis of 2-substituted 1,3,4-thiadiazole C-glycosides is described by building a heterocyclic system at the aldehyde end of a series of sugar derivatives. Acid catalyzed dehydration of the polyhydroxylic chain resulted in C-nucleoside, an analogue of tiazofurin.
    DOI:
    10.1080/15257779408009483
点击查看最新优质反应信息

文献信息

  • [EN] PHENOTHIAZINE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS DE PHÉNOTHIAZINE ET LEURS UTILISATIONS
    申请人:CAMP4 THERAPEUTICS CORP
    公开号:WO2019195789A1
    公开(公告)日:2019-10-10
    The present invention provides phenothiazine compounds, processes for their preparation, pharmaceutical compositions comprising the compounds, and the use of the compounds or the compositions in the treatment of various diseases or conditions, for example ribosomal disorders and ribosomopathies, e.g. Diamond Blackfan anemia (DBA).
    本发明提供了吩噻嗪化合物,其制备方法,包含该化合物的药物组合物,以及在治疗各种疾病或症状中使用该化合物或组合物,例如核糖体紊乱和核糖体病,例如钻石-布莱克范贫血(DBA)。
  • Method for manufacturing pigment dispersed liquid, and pigment dispersed liquid, and ink for ink-jet printer recording using said pigment dispersed liquid
    申请人:SEIKO EPSON CORPORATION
    公开号:US20020088375A1
    公开(公告)日:2002-07-11
    A method for manufacturing a pigment dispersed liquid, comprising at least: Step A of introducing a hydrophilic dispersibility-imparting group directly and/or via another atomic group to the surface of pigment particles; Step B of dispersing the pigment obtained in Step A in an aqueous medium; and Step C of conducting refining treatment of the dispersed liquid obtained in Step B.
    制造颜料分散液的方法,至少包括: 步骤A:将亲水性分散性赋予基团直接和/或通过另一个原子基团引入颜料颗粒的表面; 步骤B:将步骤A中获得的颜料分散在水性介质中; 步骤C:对步骤B中获得的分散液进行精炼处理。
  • Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
    申请人:Eckhardt Matthias
    公开号:US20050209166A1
    公开(公告)日:2005-09-22
    Glucopyranosyl-substituted benzene derivatives of general formula I where the groups R 1 to R 6 as well as R 7a , R 7b , R 7c are defined herein and the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention are suitable for the treatment of metabolic disorders.
    通用公式I的葡萄糖吡喃基取代苯衍生物,其中R1至R6基团以及R7a、R7b、R7c在此定义,并且其互变异构体、立体异构体、混合物及盐。根据本发明的化合物适用于治疗代谢紊乱。
  • Processes for preparing of glucopyranosyl-substituted (ethynyl-benzyl)-benzene derivatives and intermediates thereof
    申请人:ECKHARDT Matthias
    公开号:US20070073046A1
    公开(公告)日:2007-03-29
    The present invention relates to processes for preparing the compounds of general formula I, wherein the groups R 1 , R 2 and R 3 are defined according to claim 1 and to intermediates of said processes.
    本发明涉及制备一般式I化合物的过程,其中基团R1、R2和R3根据权利要求1定义,并涉及所述过程的中间体。
  • Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
    申请人:Himmelsbach Frank
    公开号:US20070004648A1
    公开(公告)日:2007-01-04
    Glucopyranosyloxy-substituted benzyl-benzene derivatives of the general formula I where the groups groups R 1 , R 2 , R 3a , R 3b , R 4 , R 5 , R 6 , X and R 7a , R 7b , R 7c are defined according to claim 1, including the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention are suitable for the treatment of metabolic disorders.
    根据权利要求1定义的通用公式I的葡萄糖吡喃氧基取代的苄基苯衍生物,包括基团R1、R2、R3a、R3b、R4、R5、R6、X以及R7a、R7b、R7c,包括互变异构体、立体异构体、它们的混合物以及它们的盐。根据发明的化合物适用于治疗代谢紊乱。
查看更多